GL1X · GenesisL1 explorer

MolNFT v1 · #159341 · protein

Cryo-EM structure of formyl peptide receptor 2/LIPOXIN A4 receptor in complex with gi

6OMM: “Cryo-EM structure of formyl peptide receptor 2/LIPOXIN A4 receptor in complex with gi”. Electron microscopy, 2 ligands (CLR, PLM). MolNFT v1 #159341 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6OMM
Type
protein
Length
1,142 residues
Chains
6
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P25090, P63096, P62873, P59768
Ligands
CLR, PLM

Structure

electron microscopy · 6 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
R—protein297—P25090
L—protein6——
A—protein217—P63096
B—protein336—P62873
C—protein54—P59768
E—protein232——

Ligands and binding sites

  • CLR · Cholesterol · ligand · 5 copies · chains R
  • PLM · Palmitic acid · ligand · 3 copies · chains R

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6OMM · Cryo-EM structure of formyl peptide receptor 2/lipoxin A4 receptor in complex with Gi · the same entry in another collection · chain E against E, TM-score 1.00
  • P62873 · AlphaFold monomer V2.0 prediction for guanine nucleotide-binding protein G(I)/G(S)/G(T)… · a predicted model of the same protein · chain B against A, TM-score 0.99
  • P25090 · AlphaFold monomer V2.0 prediction for N-formyl peptide receptor 2 (P25090) · a predicted model of the same protein · chain R against A, TM-score 0.92
  • P59768 · AlphaFold monomer V2.0 prediction for guanine nucleotide-binding protein G(I)/G(S)/G(O)… · a predicted model of the same protein · chain C against A, TM-score 0.90
  • P63096 · AlphaFold monomer V2.0 prediction for guanine nucleotide-binding protein G(I) subunit… · a predicted model of the same protein · chain A against A, TM-score 0.81

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.